This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€80,500,000
Total raised
-
Valuation
-
Employees
-
Founded
Latest round
Series A - November 5, 2026
Series A - €80,300,000
November 5, 2026
Oxford Science Enterprises, Cancer Research Horizons, University of Oxford
✓ verified by our desk
Team
AM
Adam Mead
Founder
BP
Beth Psaila
Founder
Open roles
Alethio Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile